ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,081.82
      0.66%
      US Tech 100
      17,120.40
      0.84%
      Dow Jones
      38,128.57
      0.11%
      Brent Oil
      88.475
      0.37%
      Bitcoin
      63,910.50
      -0.89%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Astria Therapeutics Inc (ATXS)

      7. Astria Therapeutics Inc (ATXS) News

      ATXS Astria Therapeutics Inc

      9.17
      0.00 (0.00%)
      Pre Market
      Last Updated: 08:58:57
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Astria Therapeutics Inc ATXS NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 9.17 08:58:57
      Open Price Low Price High Price Close Price Prev Close
      9.17
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/09/202408:00BWAstria Therapeutics Appoints Sunil Agarwal to Its Board of..
      4/03/202416:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
      3/25/202407:30BWAstria Therapeutics Announces Positive Initial..
      3/05/202416:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
      3/04/202417:22EDGAR2Form 8-K - Current report
      3/04/202417:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      3/04/202416:10BWAstria Therapeutics Reports Fourth Quarter and Full Year..
      3/04/202416:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/20/202408:00BWAstria Therapeutics to Present at Upcoming American Academy..
      2/14/202415:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202408:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/12/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/12/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/12/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/12/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/12/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/12/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/06/202408:00BWAstria Therapeutics to Present at Upcoming Oppenheimer 34th..
      2/05/202416:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
      1/31/202409:00EDGAR2Form 8-K - Current report
      1/31/202408:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      1/30/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/30/202409:08BWAstria Therapeutics Announces Pricing of $125 Million..
      1/30/202406:01EDGAR2Form 8-K - Current report
      1/29/202416:39EDGAR2Form 144 - Report of proposed sale of securities
      1/16/202416:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      1/05/202408:30EDGAR2Form 8-K - Current report
      1/02/202416:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      1/02/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      12/28/202314:09EDGAR2Form S-3/A - Registration statement under Securities Act of..
      12/20/202316:30EDGAR2Form 8-K - Current report
      12/15/202308:30EDGAR2Form S-3 - Registration statement under Securities Act of..
      12/04/202316:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
      11/27/202308:00BWAstria Therapeutics to Present STAR-0215 Data at the 2023..
      11/21/202308:00BWAstria Therapeutics to Present at Upcoming 6th Annual..
      11/13/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202308:06EDGAR2Form 8-K - Current report
      11/13/202308:00BWAstria Therapeutics Reports Third Quarter Financial Results..
      11/10/202308:00BWAstria Therapeutics Presents New Phase 1a Data Confirming..
      11/09/202308:00BWAstria Therapeutics to Present at Upcoming Jefferies London..
      11/03/202308:10BWAstria Therapeutics to Present New STAR-0215 Data at the..
      11/02/202316:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
      10/30/202308:00BWAstria Therapeutics to Report Third Quarter 2023 Financial..
      10/12/202317:04EDGAR2Form 8-K - Current report
      10/12/202317:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      10/12/202308:00EDGAR2Form 8-K - Current report
      10/11/202319:14BWAstria Therapeutics Announces Pricing of $64 Million..
      10/11/202317:14EDGAR2Form 8-K - Current report
      10/11/202317:10BWAstria Therapeutics Announces Exclusive Worldwide License..

      Your Recent History

      NASDAQ
      ATXS
      Astria Therapeutics
      Delayed Upgrade Clock